B.C. invests in cleaner industry and post-secondary innovation; PIC and GOC co-investments help plant-based companies use artificial intelligence; the Canadian Foundation for Animal-Assisted Support Services publishes Canada’s first voluntary national standards for animal-assisted human services, and more.
Organization: AstraZeneca
VIDO-InterVac wants $50 million for an additional level 4 biosafety lab to improve pandemic responsiveness
Speeding Canada’s response to future pandemics requires the highest level biosafety lab, facilities for exotic animals and more scientists. VIDO-InterVac is looking to the federal and Saskatchewan governments for funding.
The Short Report – Oct. 14, 2020: CIHR signs MOU to support Inuit-led health research, Health Canada accepts rolling submission for a COVID-19 vaccine candidate, and more
Facedrive’s TraceSCAN technology garners interest among companies globally; Canada’s National Digital Research Infrastructure Strategy has its first researcher council, and a new consortium takes shape to accelerate the commercialization of quantum computing.
Vaccine dispute should be a lesson for Canada-China commercialization exchanges
The vaccine candidate Ad5-nCoV that’s currently being held up from entering Canada by Chinese customs was developed using technology licensed from Canada’s National Research Council. The warning signs were all there.
NEOMED plans Montreal expansion; proves new pharma R&D model works
Montreal’s NEOMED Institute needs more space to accommodate growing demand for its facilities and services. Discussions are underway with an unnamed third party equity investor to finance the expansion of its Laval facility with a decision expected within weeks. NEOMED’s growth proves it is possible to come up with a business model that can retain top talent in a region when big pharma employers decide to move out.
AstraZeneca buys DSM’s Montreal facility
AstraZeneca has acquired the mothballed Montreal biologics manufacturing facility from DSM Biologics Inc — the second major investment the UK-based pharmaceutical firm has made in Montreal this year. AstraZeneca will begin re-commissioning the facility immediately and expects to begin full-scale production in 2009. Located adjacent to the National Research Council‘s Biotechnology Research Institute, it will…
Applied PeR$pectives
Building with CCNB-INNOV… Relationships that go a Long Way! CCNB-INNOV, the applied research and development arm of CCNB has adapted its range of services to better meet the unique needs of the regional shipbuilding industry.
 |
Applied PeR$pectives is a new monthly blog dedicated to highlighting the innovative work being done in the college and institute community. |
|---|
Fast Policy Facts
 |
December 12, 2018: Requiem for a National Network Program
|
|---|
Research Money on Twitter
Loading tweets...